Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2A Open-Label Study Evaluating the Safety and Efficacy of Low-Dose Ketamine in Children With ADNP Syndrome

NCT04388774 is registered in ClinicalTrials.gov with Alexander Kolevzon as lead sponsor.

NCT NCT04388774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04388774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2A Open-Label Study Evaluating the Safety and Efficacy of Low-Dose Ketamine in Children With ADNP Syndrome
Lead sponsor
Alexander Kolevzon
Phase
Phase 1/2
Overall status
Completed
Start date
August 19, 2020
Completion date
June 8, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adnp syndrome